Phase 2 trial of new cancer drug. Which is least likely to account for variation in results:

Name: Phase 2 trial of new cancer drug. Which is least likely to account for variation in results:
Brand: Quizplus
Rating: 4.7 (63 reviews)

Question

Quizplus · Accepted Answer

Gender is least likely to account for variation in results in a phase 2 trial of a new cancer drug compared to other factors like size and site of metastases, performance status, and prior therapy, which are directly related to the disease's characteristics and treatment history.

Phase 2 Trial of New Cancer Drug